Delivery Order SPE2DB25D3404-SPE2DB25FUQBD
- Not listed
- The Defense Logistics Agency awarded a $11,425.14 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with completion targeted for July 15, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,010.60 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This competitively awarded, firm fixed price delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a $4,198.91 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Norditropin FlexPro 10 mg/1.5 mL medication, with performance to be completed by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,283.33 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,190.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product, with an ultimate completion date of August 8, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,190.76 delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL on July 23, 2025, with completion scheduled for July 24, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency has awarded a delivery order valued at $2,432.40 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product. This firm fixed price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a child contract action under the company's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, and performance will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 ml pharmaceutical product with a ceiling value of $5,668.65. This firm fixed price delivery order, with an ultimate completion date of August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract value $999,999,999.00 through December 2026). The award was made...
- The Defense Logistics Agency awarded a delivery order valued at $2,375.41 to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL pharmaceutical product, with a firm fixed price arrangement. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQBDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,561.02 to AmerisourceBergen Drug Corp for Norditropin FlexPro 15 mg/1.5 mL pharmaceutical product on August 26, 2025, with completion targeted for August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, fulfills extensive medical procurement needs for military and veteran healthcare systems through its DLA contracts. The company's federal contract portfolio demonstrates significant capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Norditropin, a human growth hormone medication, reflects the company's ongoing role as a primary supplier of pharmaceutical products to Defense Health Agency and other federal healthcare systems through competitive procurement mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/26/25 |